Koninklijke Philips (RYLPF) Cash from Investing Activities (2009 - 2026)

Koninklijke Philips (RYLPF) recorded quarterly Cash from Investing Activities of -$475.3 million in Q1 2026, up 44.59% quarter-over-quarter from -$857.9 million in Q4 2025, and down 187.82% on a YoY basis from $541.2 million in Q1 2025.

Koninklijke Philips (RYLPF) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$475.3 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 187.82% year-over-year to -$475.3 million; the TTM figure through Mar 2026 stood at -$2.2 billion (down 33.6% YoY), while the FY2025 annual figure was -$857.9 million, down 40.11% from the prior year.
  • Cash from Investing Activities was -$475.3 million for Q1 2026 at Koninklijke Philips, up from -$857.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$165.1 million in Q1 2025 to a low of -$1.5 billion in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$584.7 million across 5 years, with a median of -$520.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 75.77% in 2022, then slumped 187.82% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.5 billion in 2022, then soared by 54.89% to -$684.3 million in 2023, then grew by 10.52% to -$612.3 million in 2024, then plunged by 40.11% to -$857.9 million in 2025, then surged by 44.59% to -$475.3 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$475.3 million (Q1 2026), -$857.9 million (Q4 2025), and -$632.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 Koninklijke Philips - - 2.07 Bn -475.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -475.32 Mn
Mar 31, 2026 -475.32 Mn
Dec 31, 2025 -857.90 Mn
Dec 31, 2025 -857.90 Mn
Sep 30, 2025 -632.46 Mn
Sep 30, 2025 -632.46 Mn
Jun 30, 2025 -254.69 Mn
Jun 30, 2025 -254.69 Mn
Mar 31, 2025 -165.15 Mn
Mar 31, 2025 -165.15 Mn
Dec 31, 2024 -612.31 Mn
Dec 31, 2024 -612.31 Mn
Sep 30, 2024 -520.56 Mn
Sep 30, 2024 -520.56 Mn
Jun 30, 2024 -363.99 Mn
Jun 30, 2024 -363.99 Mn
Mar 31, 2024 -190.11 Mn
Mar 31, 2024 -190.11 Mn
Dec 31, 2023 -684.30 Mn
Dec 31, 2023 -684.30 Mn